Table 1.
Candidate TFs associated with PLA2G2A gene expression determined by SNP2TFBS.
SNP (eQTL) rsID | Ref | Alt | Effect | eQTL tissues | Effect size | Matched TFs |
---|---|---|---|---|---|---|
rs12733637 | A | G | down | Liver | −0.39 | EBF1 |
Prostate | −0.34 | |||||
rs1891320 | C | T | up | Liver | 0.45 | ZNF263 |
Prostate | 0.50 | |||||
rs11573156 | G | C | up | Liver | 0.66 | SP1 |
Prostate | 0.68 | |||||
Ovary | 0.25 | |||||
Adipose-Visceral (Omentum) | 0.17 | |||||
Stomach | 0.19 | |||||
Heart-Atrial Appendage | 0.15 | |||||
Heart-Left Ventricle | 0.17 | |||||
rs1796923 | T | G | down | Skin-Sun Exposed (Lower leg) | −0.80 | PPARG_RXRA |
Heart-Atrial Appendage | −0.51 | |||||
Skin-Not Sun Exposed (Suprapubic) | −0.65 | |||||
Esophagus-Muscularis | −0.62 | |||||
Thyroid | −0.40 | |||||
Heart-Left Ventricle | −0.48 | |||||
Adipose-Subcutaneous | −0.48 | |||||
Esophagus-Gastroesophageal Junction | −0.54 | |||||
rs114156017 | C | T | up | Liver | 0.42 | SREBF1 SREBF2 |
Prostate | 0.41 | |||||
Adipose-Visceral (Omentum) | 0.18 | |||||
Heart-Atrial Appendage | 0.16 | |||||
rs149238894 | G | A | up | Liver | 0.40 | GATA1 |
Prostate | 0.42 | |||||
Adipose-Visceral (Omentum) | 0.18 | |||||
Heart-Atrial Appendage | 0.15 | |||||
rs139466428 | TG | T | up | Prostate | 0.38 | FOXQ1 |
Adipose-Visceral (Omentum) | 0.15 | |||||
Esophagus-Muscularis | 0.13 |
Ref , reference allele; Alt , alternative allele; Effect , the direction of the eQTL’s effect on PLA2G2A gene expression; “up” means the alternative allele upregulates PLA2G2A gene expression compared to the reference allele, and “down” means the alternative allele downregulates PLA2G2A gene expression compared to the reference allele.; eQTL tissues , tissue distribution of each eQTL; Effect size , the normalized effect size of each significant tissue-eQTL obtained from GTEx Portal, which was computed as the effect of the alternative allele relative to the reference allele in the human genome reference GRCh38/hg38; TF , transcription factor.